|
1
|
Mclnnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bansback NJ, Regier DA, Ara R, Brennan A,
Shojania K, Esdaile JM, Anis AH and Marra CA: An overview of
economic evaluations for drugs used in rheumatoid arthritis: Focus
on tumour necrosis factor-alpha antagonists. Drugs. 65:473–496.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gibofsky A: Overview of epidemiology,
pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag
Care. 18 13 Suppl:S295–S302. 2012.PubMed/NCBI
|
|
4
|
Scherer HU and Burmester GR: A clinical
perspective of rheumatoid arthritis. Eur J Immunol. 39:2044–2048.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kagan HM and Li W: Lysyl oxidase:
Properties, specificity, and biological roles inside and outside of
the cell. J Cell Biochem. 88:660–672. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khakoo A, Thomas R, Trompeter R, Duffy P,
Price R and Pope FM: Congenital cutis laxa and lysyl oxidase
deficiency. Clin Genet. 51:109–114. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Zhou J, Chen L, Luo Z and Zhao Y:
Lysyl oxidase, a critical intra- and extra-cellular target in the
lung for cigarette smoke pathogenesis. Int J Environ Res Public
Health. 8:161–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rimar D, Rosner I, Nov Y, Slobodin G,
Rozenbaum M, Halasz K, Haj T, Jiries N, Kaly L, Boulman N, et al:
Brief report: Lysyl oxidase is a potential biomarker of fibrosis in
systemic sclerosis. Arthritis Rheumatol. 66:726–730. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mesarwi OA, Shin MK, Drager LF,
Bevans-Fonti S, Jun JC, Putcha N, Torbenson MS, Pedrosa RP,
Lorenzi-Filho G, Steele KE, et al: Lysyl oxidase as a serum
biomarker of liver fibrosis in patients with severe obesity and
obstructive sleep apnea. Sleep. 38:1583–1591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baiocchini A, Montaldo C, Conigiaro A,
Grimaldi A, Correani V, Mura F, Ciccosanti F, Rotiroti N, Brenna A,
Montalbano M, et al: Extracellular matrix molecular remodeling in
human liver fibrosis evolution. PLoS One. 11:e01517362016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rankin EB and Giaccia AJ: Hypoxic control
of metastasis. Science. 352:175–180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perryman L and Erler JT: Lysyl oxidase in
cancer research. Future Oncol. 10:1709–1717. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu R, Sun B, Lin J, Song T, Li H, Wen P
and Han M: Comparison of lysyI oxidase expression between active
rheumatoid arthritis and active osteoarthritis. Chin J Rheumatol.
17:95–97. 2013.(In Chinese).
|
|
14
|
Rosloniec EF, Cremer M, Kang AH, Myers LK
and Brand DD: Collagen-induced arthritisCurrent Protocols in
Immunology. Coico R and Shevach E: John Wiley & Sons; New York:
pp. 15.5.1–15.5.25. 2010
|
|
15
|
Elhai M, Chiocchia G, Marchiol C, Lager F,
Renault G, Colonna M, Bernhardt G, Allanore Y and Avouac J:
Targeting CD226/DNAX accessory molecule-1 (DNAM-1) in
collagen-induced arthritis mouse models. J Inflamm. 12:92015.
View Article : Google Scholar
|
|
16
|
Miana M, Galán M, Martínez-Martínez E,
Varona S, Jurado-López R, Bausa-Miranda B, Antequera A, Luaces M,
Martínez-González J, Rodríguez C and Cachofeiro V: The lysyl
oxidase inhibitor β-aminopropionitrile reduces body weight gain and
improves the metabolic profile in diet-induced obesity in rats. Dis
Models Mech. 8:543–551. 2015. View Article : Google Scholar
|
|
17
|
Gao HY, Luo J, Li XF, Lv Q, Wen HY, Song
QZ, Zhao WP, Zhao XC, Zhang TT, Zhang SY and Zhi JM: Changes in
focal adhesion kinase expression in rats with collagen-induced
arthritis and efficacy of intervention with disease modifying
anti-rheumatic drugs alone or in combination. Int J Clin Exp
Pathol. 8:15573–15581. 2015.PubMed/NCBI
|
|
18
|
Amdekar S and Singh V: Lactobacillus
acidophilus maintained oxidative stress from reproductive organs in
collagen-induced arthritic rats. J Hum Reprod Sci. 9:41–46. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aciksari K, Yanar HT, Hepqul G, Ozucelik
DN, Yanar F, Agcaoglu O, Eser M, Tanriverdi G, Topacoglu H, Ayvaci
BM, et al: The effect of Beta-aminopropionitrile and prednisolone
on the prevention of fibrosis in alkali esophageal burns: An
experimental study. Gastroenterology Res Pract.
2013:5742602013.
|
|
20
|
Jutley G, Raza K and Buckley CD: New
pathogenic insights into rheumatoid arthritis. Curr Opin Rheumatol.
27:249–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haag S, Tuncel J, Thordardottir S, Mason
DE, Yau AC, Dobritzsch D, Bäcklund J, Peters EC and Holmdahl R:
Positional identification of RT1-B (HLA-DQ) as susceptibility locus
for autoimmune arthritis. J Immunol. 194:2539–2550. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klimiuk PA, Domysławska I, Sierakowski S
and Chwiećko J: Regulation of serum matrix metalloproteinases and
tissue inhibitor of metalloproteinases-1 following rituximab
therapy in patients with rheumatoid arthritis refractory to
anti-tumor necrosis factor blockers. Rheumatol Int. 35:749–755.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mc Ardle A, Flatley B, Pennington SR and
FitzGerald O: Early biomarkers of joint damage in rheumatoid and
psoriatic arthritis. Arthritis Res Ther. 17:1412015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yue B: Biology of the extracellular
matrix: An overview. J Glaucoma. 23 8 Suppl 1:S20–S23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giannandrea M and Parks WC: Diverse
functions of matrix metalloproteinases during fibrosis. Dis Model
Mech. 7:193–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pap T, Shigeyama Y, Kuchen S, Fernihough
JK, Simmen B, Gay RE, Billingham M and Gay S: Differential
expression pattern of membrane-type matrix metalloproteinases in
rheumatoid arthritis. Arthritis Rheum. 43:1226–1232. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elshabrawy HA, Chen Z, Volin MV, Ravella
S, Virupannavar S and Shahrara S: The pathogenic role of
angiogenesis in rheumatoid arthritis. Angiogenesis. 18:433–448.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pu J, Fang FF, Li XQ, Shu ZH, Jiang YP,
Han T, Peng W and Zheng CJ: Matrine exerts a strong anti-arthritic
effect on type II collagen-induced arthritis in rats by inhibiting
inflammatory responses. Int J Mol Sci. 17(pii): E14102016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou M, Qin S, Chu Y, Wang F, Chen L and
Lu Y: Immunolocalization of MMP-2 and MMP-9 in human rheumatoid
synovium. Int J Clin Exp Pathol. 7:3048–3056. 2014.PubMed/NCBI
|
|
31
|
Xue M, McKelvey K, Shen K, Minhas N, March
L, Park SY and Jackson CJ: Endogenous MMP-9 and not MMP-2 promotes
rheumatoid synovial fibroblast survival, inflammation and cartilage
degradation. Rheumatology (Oxford). 53:2270–2079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Itoh Y: Metalloproteinases: Potential
therapeutic targets for rheumatoid arthritis. Endocr Metab Immune
Disord Drug Targets. 15:216–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
